SCHEMBL6743790

SCHEMBL6743790

FC(F)(F)c1cnc(OCc2ccccc2)c(Cl)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.71
SMN1; SMN2 Q16637 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56
ALDH1A1 P00352 3/20 0.55
RAB9A P51151 1/20 0.54
HPGD P15428 2/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
LMNA P02545 3/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 2/20 0.48
XBP1 P17861 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.48
GLA P06280 2/20 0.48
LIPE Q05469 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9421429 0.87 SMN1; SMN2 (0.65) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL8637639 0.85 RAB9A (0.55) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL22469762 0.84 MRGPRX4 (1.00) MRGPRX4SMN1; SMN2RAB9AHPGDKMT2A
SCHEMBL31568457 0.84 MRGPRX4 (1.00) MRGPRX4SMN1; SMN2RAB9AHPGDKMT2A
SCHEMBL8431628 0.84 MRGPRX4 (0.52) MRGPRX4CYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL4160021 0.84 MRGPRX4 (0.52) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL4284174 0.84 MRGPRX4 (0.52) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL27382834 0.83 RAB9A (0.59) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL7916623 0.82 MRGPRX4 (0.51) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL30104807 0.82 MRGPRX4 (0.51) MRGPRX4SMN1; SMN2CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040043903-A1 Herbicides; applying to plants BASF AKTIENGESELLSCHAFT (DE) 2004-03-04 US disclosed
EP-1335903-A1 2-ARYL-5-TRIFLUOROMETHYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2003-08-20 EP disclosed
WO-2002042275-A1 2-ARYL-5-TRIFLUOROMETHYLPYRIDINES BASF AKTIENGESELLSCHAFT (DE) 2002-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043903-A1 Herbicides; applying to plants DDT, DRD1, DRD4 MRGPRX4 1467/4885SMN1; SMN2 4597/4885CYP1A2 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.